TAVI study aims to uncover kidney risks from contrast dye
NCT ID NCT07626710
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study observes 1000 people with severe aortic stenosis and kidney disease who are getting a TAVI procedure. Researchers want to see how removing the blocked valve affects the kidneys' response to contrast dye used during the procedure. The goal is to understand if TAVI lowers the risk of kidney injury from the dye.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict and prevent kidney damage after TAVI procedures.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test a new therapy, and results may not change current practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Enrico Romagnoli
RECRUITINGRoma, RM, 00168, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new heart valve match the safety of proven ones?
- Can a new graft keep dialysis access working longer?
- Can a common gout pill shield hearts in kidney disease?
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes